The impact of PTSD treatment on the cortisol awakening response

Depression and Anxiety

Volumn 31, Issue 10, 2014, Pages 862-869

  Pacella, Maria L ^a   Feeny, Norah ^b   Zoellner, Lori ^c   Delahanty, Douglas L ^d  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d KENT STATE UNIVERSITY   (United States)

Author keywords

Cortisol; Gender; Posttraumatic; Prolonged exposure; Sertraline; Stress disorders; Treatment

Indexed keywords

HYDROCORTISONE; SERTRALINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; AROUSAL; ARTICLE; CLINICAL ARTICLE; CORTISOL AWAKENING RESPONSE; DEPRESSION; FEMALE; GENDER; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LONG TERM EXPOSURE; MALE; OUTCOME ASSESSMENT; POSTTRAUMATIC STRESS DISORDER; PSYCHOPHARMACOTHERAPY; TREATMENT RESPONSE; CHEMISTRY; CONTROLLED STUDY; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMPLOSIVE THERAPY; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SALIVA; SEX DIFFERENCE; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMPLOSIVE THERAPY; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; SALIVA; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SEX FACTORS; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 84914099540     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22298     Document Type: Article

References (52)

1. Kessler RC, Berglund P, Dernier O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 2005;62:593-602.
2. Pietrzak RH, Goldstein RB, Southwick, SM, Grant, BF. Prevalence and axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions. J Anxiety Disord 2011;25:456-465.
3. Pacella ML, Hruska B, Delahanty, DL. The physical health consequences of PTSD and PTSD symptoms: a meta-analytic review. J Anxiety Disord 2013;27:33-46.
4. Bisson J, Brayne M, Ochberg F, Everly G. Early psychosocial intervention following traumatic events. Am J Psychiatry 2007;164:1016-1019.
5. Bradley R, Greene J, Russ E, et al. A multidimensional meta-analysis of psychotherapy for PTSD. Am J Psychiatry 2005;162:214-227.
6. Ipser JC, Stein DJ. Evidence-based pharmacotherapy of posttraumatic stress disorder (PTSD). Int J Neuropsychopharmacol 2012;15:825-840.
7. Powers MB, Halpern JM, Ferenschak MP, et al. A meta-analytic review of prolonged exposure for posttraumatic stress disorder. Clin Psychol Rev 2010;30:635-641.
8. Steckler T, Risbrough V. Pharmacological treatment of PTSD - established and new approaches. Neuropharmacology 2012;62:617-627.
9. Foa EB, Keane T, Friedman M, Cohen J, editors. Effective Treatments for PTSD: Practice Guidelines from the International Society for Traumatic Stress Studies. New York: Guilford Press; 2009.
10. Resick PA, Williams LF, Suvak MK, et al. Long-term outcomes of cognitive-behavioral treatments for posttraumatic stress disorder among female rape survivors. J Counsult Clin Psychol 2012;80:201-210.
11. VA/DoD Guideline Working Group (2010). VA/DoD clinical practice guideline for management of post-traumatic stress. Available at: http://www.healthquality.va.gov/ptsd/ptsd-sum-2010a.pdf
12. Jeffreys M. Clinican's guide to medications for PTSD. National Center for PTSD; 2009. Available at: http://www.ptsd.va.gov/professional/pages/clinicians-guide-to-medications-for-ptsd.asp.
13. Stein DJ, Ipser J, McAnda N Pharmacotherapy of posttraumatic stress disorder: a review of meta-analyses and treatment guidelines. CNS Spectr 2009;14:25-31.
14. Mushtaq D, Ali A, Margoob MA, et al. Association between serotonin transporter gene promoter-region polymorphism and 4-and 12-week treatment response to sertraline in posttraumatic stress disorder. J Affect Disord 2012;136:955-962.
15. De Kloet CS, Vermetten E, Geuze E, Kavelaars AMAA, Heijnen CJ, Westenberg HGM. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review. J Psychiatr Res 2006;40(6):550-567.
16. Gerardi M, Rothbaum BO, Astin M, Kelley M. Cortisol response following exposure treatment for PTSD in rape victims. J Aggress Maltreat Trauma 2010;19:349-356.
17. Olff M, de Vries G-J, Guzelcan Y, et al. Changes in cortisol and DHEA plasma levels after psychotherapy for PTSD. Psychoneuroendocrinology 2007;32:619-626.
18. Tucker P, Ruwe WD, Masters B, et al. Nueroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder. Biol Psychiatr 2004;56:121-128.
19. Rothbaum, B.O., Price, M., Jovanovic, T., et al. A randomized, double-blind evaluation of D-Cycloserine or Alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder (PTSD) in OEF/OIF war Veterans. Am J Psychiatry 2014;171(6):640-648.
20. Heim C, Nemeroff CB. Neurobiology of posttraumatic stress disorder. CNS Spectr 2009;14(1 Suppl 1):13-24.
21. Pace TWW, Heim CH. A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities. Brain Behav Immun 2011;25:6-13.
22. Wessa M, Rohleder N. Endocrine and inflammatory alterations in post-traumatic stress disorder. Expert Rev Endocrinol Metab 2007;2:91-122.
23. Meewisse ML, Reitsma JB, De Vries GJ, et al. Cortisol and post-traumatic stress disorder in adults Systematic review and meta-analysis. BR J Psychiatry 2007;191:387-392.
24. Chida Y, Steptoe A. Cortisol awakening response and psychosocial factors: a systematic review and meta-analysis. Biolpsychol 2009;80:265-278.
25. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003;28:916-931.
26. Clow A, Hucklebridge F, Stalder T, et al. The cortisol awakening response: more than a measure of HPA axis function. Neurosci Biobehav Rev 2010;35:97-103.
27. Hellhammer J, Fries E, Schweisthal OW, et al. Several daily measurements are necessary to reliably assess the cortisol rise after awakening: state-and trait components. Psychoneuroendocrinology 2007;32:80-86.
28. Kudielka BM, Kirschbaum, C. Sex differences in HPA axis responses to stress: a review. Biol Psychol 2005;69:113-132.
29. Inslicht SS, Otte C, McCaslin SE, et al. Cortisol awakening response prospectively predicts peritraumatic and acute stress reactions in police officers. Biol Psychiatr 2011;70:1055-1062.
30. Foa E, Hembree E, Rothbaum BO. Prolonged Exposure Therapy for PTSD: Emotional Processing of Traumatic Experiences Therapist Guide. New York, NY: Oxford University Press; 2007.
31. Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder. JAMA 2000;283:1837-1844.
32. Foa EB, Rothbaum BO, editors. Treating the Trauma of Rape. 9th ed. New York, NY: Guilford Press; 1998.
33. Marshall RD, Beebe KL, Oldham M, Zaninelli R. Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry 2001;158:1982-1988.
34. Foa EB, Riggs DS, Dancu CV, Rothbaum BO. Reliability and validity of a brief instrument for assessing post-traumatic stress disorder. J Trauma Stress 1993;6:459-473.
35. First MB, Gibbon M, Spitzer RL, Williams JBW. Structured Clinical Interview for DSM-IV Personality Disorders (SCID-II). Washington, DC: American Psychiatric Press, Inc; 1997.
36. Regier DA, Narrow WE, Clarke DE, et al. DSM-5 field trials in the United States and Canada, part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry 2003;170(1):59-70.
37. Kraemer HC, Kupfer DJ, Clarke DE, Narrow WE, Regier DA. DSM-5: how reliable is reliable enough? Am J Psychiatry 2012;169(1):13-15.
38. Beck AT, Ward C, Mendelson M. Beck depression inventory (BDI). Arch Gen Psychiatry 1961;4:561-571.
39. Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988;8:77-100.
40. Dressendorfer RA, Kirschbaum C, Rohede W, et al. Synthesis of a cortisol-biotin conjugate and evaluation as tracer in an immunoassay for salivary cortisol measurement. J Steroid Biochem Mol Biol 1992;43:683-692.
41. SPSS Inc. SPSS Statistics Version 21 [Computer software]. Chicago, IL: SPSS, Inc; 2012.
42. Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 2002;59:877-883.
43. De Kloet CS, Vermetten E, Heijnen CJ, Geuze E, Lentjes EGWM, Westenberg HGM. Enhanced cortisol suppression in response to dexamethasone administration in traumatized veterans with and without posttraumatic stress disorder. Psychoneuroendocrinology 2007;32(3):215-226.
44. Blain LM, Galovski TE, Robinson T. Gender differences in recovery from posttraumatic stress disorder: a critical review. Aggress Violent Behav 2010;15(6):463-474.
45. Carlson LE, Speca M, Patel KD, Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin inbreast and prostate cancer outpatients. Psychoneuroendocrinology 2004;29(4):448-474.
46. Fries E, Dettenborn L, Kirschbaum C. The cortisol awakening response (CAR): facts and future directions. Int J Psychophysiol 2009;72:67-73.
47. Tolin DF, Foa EB. Sex differences in trauma and posttraumatic stress disorder: a quantitative review of 25 years of research. Psychol Bull 2006;132:959-992.
48. Mills KL, Teesson M, Back SE, et al. Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial. JAMA 2012;308(7):690-699.
49. Rytwinski NK, Scur MD, Feeny NC, Youngstrom EA. The cooccurrence of major depressive disorder among individuals with posttraumatic stress disorder: a meta-analysis. J Trauma Stress 2013;26(3):299-309.
50. Araújo AX, Berger W, Coutinho ESF, et al. Comorbid depressive symptoms in treatment-seeking PTSD outpatients affect multiple domains of quality of life. Compr Psychiatry 2014;55(1):56-63.
51. Gola H, Engler H, Schauer M, et al. Victims of rape show increased cortisol responses to trauma reminders: a study in individuals with war-and torture-related PTSD. Psychoneuroen-docrinology 2012;37(2):213-220.
52. Irish LA, Gabert-Quillen CA, Ciesla JA, Pacella ML, Sledjeski EM, Delahanty DL. An examination of PTSD symptoms as a mediator of the relationship between trauma history characteristics and physical health following a motor vehicle accident. Depress Anxiety 2013;30(5):475-482.